CLYM Climb Bio, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$10.94
· of 52w range
· above low
· to high
$1.5452w low
$18.3352w high
Market Cap (MRQ)
$628M
P/E
-12.4
EPS
$-0.88
your badges
52W Range
$2–$18
Analyst Rating
STRONG BUY
Price Target
$28
P/E
-12.4
ROE
-34.6%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
CLYM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.94
Market Cap (MRQ)
$628M
P/E
-12.4
EPS
$-0.88
ROE
-34.6%
52W Range
$2–$18
CLYM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-0.882021-12-31 → 2025-12-31
Free Cash Flow$-55M2024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CLYM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -12.45Y avg ≈-2.5 | ≈-2.5 | · | · | |
| P/B (MRQ) | 2.65Y avg ≈1.0 | ≈1.0 | 4.0 | Undervalued | |
| Price / FCF | -9.6 | · | · | · | |
| Price / Cash Flow | -9.65Y avg ≈-5.4 | ≈-5.4 | · | · | |
| Price / Tangible Book | 3.35Y avg ≈1.0 | ≈1.0 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CLYM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -31.1%5Y avg ≈-38.4% | ≈-38.4% | -44.6% | Top tier | |
| ROE | -34.6%5Y avg ≈-32.7% | ≈-32.7% | -55.2% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CLYM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 31.55Y avg ≈23.3 | ≈23.3 | 12.9 | Strong liquidity | |
| Quick Ratio | 14.55Y avg ≈22.0 | ≈22.0 | 5.2 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-14.0%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 18, 2026 | $-0.18 | $-0.22 | 17.4% |
| March 31, 2026 | May 19, 2026 | $-0.20 | $-0.27 | 26.5% |
| Dec. 31, 2025 | $-0.26 | $-0.20 | -29.4% | |
| Sept. 30, 2025 | $-0.19 | $-0.15 | -27.0% | |
| June 30, 2025 | $-0.13 | $-0.19 | 31.1% | |
| March 31, 2025 | $-0.31 | $-0.15 | -102.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $47M | $14M | $15M | $26M | $23M | $9M | |
| SG&A Expense | $21M | $16M | $25M | $19M | $12M | $2M | |
| Operating Expenses | $68M | $82M | $40M | $45M | $36M | $21M | |
| Operating Income | $-68M | $-82M | $-40M | $-45M | $-36M | $-21M | |
| Interest Income | $8M | $8M | $5M | · | · | · | |
| Other Non-op | $8M | $8M | $5M | $-109.0K | $-12M | $257.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-60M | $-74M | $-35M | $-45M | $-47M | $-21M | |
| EPS (Basic) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | · | |
| EPS (Diluted) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | · | |
| Shares (Basic) | 67,812,145 | 48,163,301 | 26,987,122 | 26,311,554 | 12,260,551 | · | |
| Shares (Diluted) | 67,812,145 | 48,163,301 | 26,987,122 | 26,311,554 | 12,260,551 | 2,187,813 | |
| EBITDA | $-68M | $-82M | · | $-45M | $-36M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $36M | $87M | $93M | $44M | $47M | $20M | |
| Short-term Investments | $65M | $64M | $14M | $80M | $90M | $0 | |
| Prepaid Expense | $5M | $4M | $3M | $11M | $12M | $2M | |
| Current Assets | $106M | $155M | $110M | $134M | $148M | $22M | |
| PP&E (Net) | $288.0K | $199.0K | · | · | · | · | |
| Other Non-current Assets | $2M | $16.0K | $15.0K | $128.0K | $70.0K | $3M | |
| Total Assets | $168M | $217M | $110M | $135M | $173M | $25M | |
| Accounts Payable | $2M | $705.0K | $66.0K | $750.0K | $1M | $1M | |
| Accrued Liabilities | · | $4M | $2M | $5M | $5M | $1M | |
| Current Liabilities | $7M | $5M | $3M | $6M | $6M | $3M | |
| Capital Leases | $285.0K | $375.0K | $15.0K | $180.0K | $0 | · | |
| Other Non-current Liabilities | · | $0 | $22.0K | $0 | $7.0K | $0 | |
| Total Liabilities | $7M | $5M | $3M | $6M | $6M | $3M | |
| Common Stock | $5.0K | $7.0K | $3.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-290M | $-230M | $-156M | $-121M | $-76M | $-28M | |
| AOCI | $435.0K | $23.0K | $-2.0K | $-358.0K | $-123.0K | $0 | |
| Stockholders' Equity | $160M | $212M | $108M | $129M | $167M | $-25M | |
| Liabilities + Equity | $168M | $217M | $110M | $135M | $173M | $25M | |
| Shares Outstanding | 47,766,338 | 67,255,434 | 27,699,446 | 26,567,681 | 26,567,681 | 3,418,751 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $97.0K | $0 | · | · | · | · | |
| Stock-based Comp | $8M | $6M | $13M | $7M | $4M | $707.0K | |
| Other Non-cash | $-3M | · | · | · | · | · | |
| Operating Cash Flow | $-54M | $-16M | $-21M | $-37M | $-36M | $-14M | |
| CapEx | $186.0K | $0 | $0 | · | · | · | |
| Investing Cash Flow | $3M | $-121M | $69M | $34M | $-115M | $8M | |
| Stock Issued | · | $11M | $841.0K | $0 | $149.0K | · | |
| Net Stock Activity | · | $11M | · | · | $149.0K | · | |
| Financing Cash Flow | $-21.0K | $131M | $841.0K | $0 | $177M | $5M | |
| Net Change in Cash | $-52M | $-6M | $50M | $-3M | $26M | $-736.0K | |
| Free Cash Flow | $-55M | $-20M | · | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -31.1% | -45.1% | · | -29.4% | -48.0% | · | |
| ROE | -34.6% | -34.3% | · | -34.4% | -27.6% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 15.2 | 31.4 | · | 22.0 | 24.6 | · | |
| Quick Ratio | 14.5 | 30.6 | · | 20.3 | 22.6 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.36 | $3.15 | · | $4.84 | $6.37 | · | |
| Cash Flow / Share | $-0.80 | $-0.32 | · | $-1.42 | $-2.94 | · | |
| Cash / Share | $0.75 | $1.30 | · | $1.64 | $1.79 | · | |
| EPS (TTM) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-60M | $-74M | $-35M | $-45M | $-47M | · | |
| Market Cap | $191M | $121M | · | $98M | $274M | · | |
| P/E | -4.5 | -1.2 | -2.1 | -2.1 | -2.5 | · | |
| P/B | 1.2 | 0.6 | · | 0.8 | 1.6 | · | |
| P / Tangible Book | 1.2 | 0.6 | 0.7 | 0.8 | 1.6 | · | |
| P / Cash Flow | -3.5 | -7.8 | · | -2.6 | -7.6 | · | |
| P / FCF | -3.5 | -6.0 | · | · | · | · | |
| Earnings Yield | -22.0% | -85.0% | -48.1% | -46.9% | -40.5% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $10M | $9M | $14M | $9M | $7M | $17M | $6M | $6M | $1M | $1M | $3M | $3M | $4M | $6M | $5M | $4M | |
| SG&A Expense | $6M | $6M | $6M | $6M | $4M | $6M | $5M | $5M | $4M | $2M | $2M | $2M | $3M | $18M | $5M | $4M | |
| Operating Expenses | $15M | $15M | $19M | $15M | $11M | $23M | $11M | $12M | $56M | $3M | $5M | $5M | $7M | $23M | $10M | $9M | |
| Operating Income | $-15M | $-15M | $-19M | $-15M | $-11M | $-23M | $-11M | $-12M | $-56M | $-3M | $-5M | $-5M | $-7M | $-23M | $-10M | $-9M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $1M | · | · | · | · | · | · | · | |
| Other Non-op | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $-934.0K | |
| Income Tax | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-13M | $-14M | $-18M | $-13M | $-9M | $-21M | $-8M | $-9M | $-55M | $-2M | $-4M | $-4M | $-5M | $-22M | $-8M | $-10M | |
| EPS (Basic) | $-0.18 | $-0.20 | $-0.25 | $-0.19 | $-0.13 | $-0.31 | $0.47 | $-0.13 | $-1.81 | $-0.06 | $-0.12 | $-0.15 | $-0.19 | $-0.84 | $-0.48 | $-0.37 | |
| EPS (Diluted) | $-0.18 | $-0.20 | $-0.25 | $-0.19 | $-0.13 | $-0.31 | $0.47 | $-0.13 | $-1.81 | $-0.06 | $-0.12 | $-0.15 | $-0.19 | $-0.84 | $-0.48 | $-0.37 | |
| Shares (Basic) | 76,154,071 | 68,207,313 | · | 68,003,248 | 67,585,121 | 67,462,450 | · | 67,014,183 | 30,349,562 | 27,638,528 | · | 27,071,053 | 26,840,555 | 26,492,438 | · | 26,336,029 | |
| Shares (Diluted) | 76,154,071 | 68,207,313 | · | 68,003,248 | 67,585,121 | 67,462,450 | · | 67,014,183 | 30,349,562 | 27,638,528 | · | 27,071,053 | 26,840,555 | 26,492,438 | · | 26,336,029 | |
| EBITDA | $-15M | $-15M | · | $-15M | $-11M | $-23M | · | $-12M | $-56M | $-3M | · | $-5M | $-7M | $-23M | · | $-9M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $8M | $36M | $26M | $23M | $29M | $87M | $146M | $223M | $105M | $93M | $57M | $25M | $34M | $44M | $36M | |
| Short-term Investments | $139M | $101M | $65M | $61M | $62M | $69M | $64M | $47M | $0 | $0 | $14M | $50M | $77M | $75M | $80M | $87M | |
| Prepaid Expense | $4M | $4M | $5M | $4M | $3M | $2M | $4M | $4M | $3M | $4M | $3M | $5M | $12M | $11M | $11M | $11M | |
| Current Assets | $187M | $113M | $106M | $91M | $87M | $100M | $155M | $198M | $226M | $109M | $110M | $112M | $114M | $120M | $134M | $133M | |
| PP&E (Net) | $695.0K | $250.0K | $288.0K | $318.0K | $314.0K | · | $199.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $1M | $226.0K | $16.0K | $0 | $0 | $0 | $15.0K | $15.0K | $2M | $1M | $128.0K | $141.0K | |
| Total Assets | $246M | $152M | $168M | $182M | $192M | $201M | $217M | $222M | $226M | $109M | $110M | $113M | $116M | $122M | $135M | $141M | |
| Accounts Payable | $1M | $860.0K | $2M | $477.0K | $946.0K | $777.0K | $705.0K | $291.0K | $509.0K | $85.0K | $66.0K | $736.0K | $878.0K | $864.0K | $750.0K | $1M | |
| Accrued Liabilities | · | · | · | · | · | $6M | · | $3M | $3M | $3M | $2M | $2M | $2M | $4M | $5M | $4M | |
| Current Liabilities | $6M | $4M | $7M | $5M | $6M | $7M | $5M | $3M | $4M | $3M | $3M | $3M | $4M | $5M | $6M | $6M | |
| Capital Leases | $813.0K | $216.0K | $285.0K | $352.0K | $417.0K | $319.0K | $375.0K | $0 | $0 | $0 | $15.0K | $58.0K | $100.0K | $223.0K | $180.0K | $219.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $0 | $22.0K | $34.0K | $55.0K | $87.0K | $0 | $0 | |
| Total Liabilities | $7M | $4M | $7M | $5M | $7M | $7M | $5M | $3M | $4M | $3M | $3M | $3M | $4M | $5M | $6M | $6M | |
| Common Stock | $6.0K | $5.0K | $5.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-317M | $-303M | $-290M | $-272M | $-259M | $-251M | $-230M | $-221M | $-213M | $-158M | $-156M | $-152M | $-148M | $-143M | $-121M | $-113M | |
| AOCI | $-67.0K | $157.0K | $435.0K | $469.0K | $318.0K | $286.0K | $23.0K | $201.0K | $0 | $0 | $-2.0K | $-11.0K | $-35.0K | $-95.0K | $-358.0K | $-581.0K | |
| Stockholders' Equity | $240M | $148M | $160M | $177M | $186M | $193M | $212M | $219M | $222M | $106M | $108M | $110M | $113M | $117M | $129M | $134M | |
| Liabilities + Equity | $246M | $152M | $168M | $182M | $192M | $201M | $217M | $222M | $226M | $109M | $110M | $113M | $116M | $122M | $135M | $141M | |
| Shares Outstanding | 57,436,255 | 47,768,543 | 47,766,338 | 68,184,435 | 67,764,100 | 67,575,767 | 67,255,434 | 67,223,760 | 66,785,449 | 27,723,824 | 27,699,446 | 27,466,005 | 26,994,988 | 26,973,875 | 26,567,681 | 26,567,681 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $33.0K | $38.0K | $30.0K | $29.0K | $38.0K | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $1M | $2M | $1M | $4M | $1M | $2M | $2M | $3M | $512.0K | $465.0K | $1M | $656.0K | $777.0K | $10M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $0 | $2M | $200.0K | $700.0K | $16M | · | · | |
| Other Non-cash | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-11M | $-14M | $-16M | $-12M | $-11M | $-15M | $-6M | $-8M | $-667.0K | $-2M | $-947.0K | $3M | $-8M | $-15M | $-8M | $-4M | |
| CapEx | · | · | $0 | $109.0K | · | · | $0 | $-5M | · | · | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | $-57M | $-13M | $26M | $15M | $5M | $-43M | $-53M | $-72M | $-10M | $14M | $37M | $28M | $-2M | $6M | $14M | $9M | |
| Stock Issued | · | · | · | · | · | $0 | · | $2M | $9M | $15.0K | $288.0K | $528.0K | $24.0K | $1.0K | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $15.0K | · | · | · | $1.0K | · | · | |
| Financing Cash Flow | $104M | $5.0K | $-21.0K | $0 | $0 | $0 | $41.0K | $2M | $128M | $15.0K | $288.0K | $528.0K | $24.0K | $1.0K | $0 | $0 | |
| Net Change in Cash | $36M | $-27M | $10M | $3M | $-6M | $-58M | $-59M | $-77M | $118M | $12M | $36M | $32M | $-9M | $-9M | $8M | $3M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -6.2% | -7.8% | · | -6.4% | -4.1% | -13.4% | · | -5.3% | -32.1% | -1.5% | · | -3.1% | -3.9% | -15.7% | · | -6.0% | |
| ROE | -6.3% | -8.0% | · | -6.5% | -4.2% | -13.9% | · | -5.4% | -32.8% | -1.5% | · | -3.2% | -4.1% | -16.4% | · | -6.2% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 31.5 | 27.9 | · | 18.4 | 14.1 | 14.3 | · | 57.7 | 60.4 | 37.0 | · | 38.8 | 31.6 | 24.5 | · | 21.2 | |
| Quick Ratio | 30.9 | 26.9 | · | 17.6 | 13.7 | 13.9 | · | 56.5 | 59.6 | 35.6 | · | 37.0 | 28.4 | 22.3 | · | 19.5 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.17 | $3.10 | · | $2.60 | $2.74 | $2.86 | · | $3.25 | $3.33 | $3.84 | · | $4.00 | $4.17 | $4.33 | · | $5.06 | |
| Cash Flow / Share | · | $-0.21 | · | · | · | $-0.23 | · | · | · | $-0.07 | · | · | · | $-0.57 | · | · | |
| Cash / Share | $0.77 | $0.17 | · | $0.38 | $0.33 | $0.43 | · | $2.17 | $3.34 | $3.79 | · | $2.09 | $0.94 | $1.28 | · | $1.35 | |
| EPS (TTM) | $-0.82 | $-0.77 | · | $-0.16 | $-0.10 | $-1.78 | · | $-2.12 | $-2.14 | $-0.52 | · | $-1.66 | $-1.88 | $-2.06 | · | $0.01 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-58M | $-53M | · | $-51M | $-47M | $-93M | · | $-69M | $-64M | $-15M | · | $-39M | $-45M | $-54M | · | $-48M | |
| Market Cap | $749M | $327M | · | $137M | $84M | $82M | · | $342M | $475M | $76M | · | $72M | $76M | $78M | · | $86M | |
| P/E | -15.9 | -8.9 | · | -12.6 | -12.4 | -0.7 | · | -2.4 | -3.3 | -5.3 | · | -1.6 | -1.5 | -1.4 | · | 323.0 | |
| P/B | 3.1 | 2.2 | · | 0.8 | 0.5 | 0.4 | · | 1.6 | 2.1 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | |
| P / Tangible Book | 3.1 | 2.2 | · | 0.8 | 0.5 | 0.4 | · | 1.6 | 2.1 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | |
| P / Cash Flow | · | -22.8 | · | · | · | -5.3 | · | · | · | -41.8 | · | · | · | -5.2 | · | · | |
| Earnings Yield | -6.3% | -11.2% | · | -8.0% | -8.1% | -145.9% | · | -41.6% | -30.1% | -19.0% | · | -63.1% | -67.1% | -71.0% | · | 0.31% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-60M | $-74M | $-35M | $-45M | $-47M |
| Diluted EPS | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 15.2 | 31.4 | · | 22.0 | 24.6 |
| Quick Ratio | 14.5 | 30.6 | · | 20.3 | 22.6 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-55M | $-20M | · | · | · |
Institutional owners (13F) 116 filers · $682.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
116
Value held
$682.3M
New positions
52
Exited positions
22
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 52 (+22 vs prior Q) | 22 (+14 vs prior Q) | 32 (+8 vs prior Q) | 19 (-4 vs prior Q) | +24.0M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $115,026,714 | 8,821,067 | 16.86% | Shares |
| FMR LLC | $88,546,347 | 6,790,364 | 12.98% | Shares |
| UBS Group AG | $44,399,453 | 3,404,866 | 6.51% | Shares |
| BRAIDWELL LP | $36,477,770 | 2,797,375 | 5.35% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $32,678,240 | 2,506,000 | 4.79% | Shares |
| BlackRock, Inc. | $30,707,531 | 2,354,872 | 4.50% | Shares |
| Cormorant Asset Management, LP | $27,462,240 | 2,106,000 | 4.02% | Shares |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $25,284,808 | 1,939,019 | 3.71% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $22,150,448 | 1,698,654 | 3.25% | Shares |
| Woodline Partners LP | $20,633,075 | 1,582,291 | 3.02% | Shares |
| CITADEL ADVISORS LLC | $16,925,555 | 1,297,972 | 2.48% | Shares |
| Redmile Group, LLC | $15,991,343 | 1,226,330 | 2.34% | Shares |
| GREAT POINT PARTNERS LLC | $13,040,000 | 1,000,000 | 1.91% | Shares |
| Affinity Asset Advisors, LLC | $12,674,880 | 972,000 | 1.86% | Shares |
| MILLENNIUM MANAGEMENT LLC | $11,842,902 | 908,198 | 1.74% | Shares |
| ADAR1 Capital Management, LLC | $10,727,343 | 822,649 | 1.57% | Shares |
| Driehaus Capital Management LLC | $10,301,600 | 790,000 | 1.51% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $10,202,039 | 782,199 | 1.50% | Shares |
| STEMPOINT CAPITAL LP | $9,685,395 | 742,745 | 1.42% | Shares |
| STATE STREET CORP | $8,955,507 | 686,772 | 1.31% | Shares |
| AMERIPRISE FINANCIAL INC | $8,579,978 | 657,971 | 1.26% | Shares |
| Parkman Healthcare Partners LLC | $7,347,831 | 563,484 | 1.08% | Shares |
| SUPERSTRING CAPITAL MANAGEMENT LP | $6,794,909 | 521,082 | 1.00% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $6,308,061 | 483,747 | 0.92% | Shares |
| VANGUARD GROUP INC | $5,362,016 | 1,340,504 | 0.79% | Shares |
| Invesco Ltd. | $4,869,724 | 373,445 | 0.71% | Shares |
| MORGAN STANLEY | $4,760,747 | 365,088 | 0.70% | Shares |
| NAN FUNG TRINITY (HK) LTD | $4,702,928 | 360,654 | 0.69% | Shares |
| NORTHERN TRUST CORP | $4,306,981 | 330,290 | 0.63% | Shares |
| Ikarian Capital, LLC | $3,912,000 | 300,000 | 0.57% | Shares |
| TD Asset Management Inc | $3,483,010 | 267,102 | 0.51% | Shares |
| Qube Research & Technologies Ltd | $3,477,103 | 266,649 | 0.51% | Shares |
| Ally Bridge Group (NY) LLC | $3,249,203 | 249,172 | 0.48% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3,125,127 | 239,657 | 0.46% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $3,123,319 | 239,451 | 0.46% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,543,335 | 195,041 | 0.37% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $2,512,808 | 192,700 | 0.37% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $2,381,691 | 182,645 | 0.35% | Shares |
| FIFTH THIRD BANCORP | $2,150,596 | 164,923 | 0.32% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2,147,844 | 164,712 | 0.31% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,933,024 | 148,238 | 0.28% | Shares |
| JANE STREET GROUP, LLC | $1,718,163 | 131,761 | 0.25% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1,699,112 | 130,300 | 0.25% | Shares |
| ArchPoint Investors | $1,680,856 | 128,900 | 0.25% | Shares |
| Schonfeld Strategic Advisors LLC | $1,644,838 | 126,138 | 0.24% | Shares |
| Bank of New York Mellon Corp | $1,612,501 | 123,658 | 0.24% | Shares |
| KOTLER KEVIN | $1,600,000 | 400,000 | 0.23% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,364,427 | 104,634 | 0.20% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $1,262,364 | 96,807 | 0.19% | Shares |
| Nuveen, LLC | $1,120,592 | 85,935 | 0.16% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P., RA Capital Nexus Fund III, L.P. ×11 filings | July 7, 2026 | 33.00% | Amendment | Board campaign | SEC |
| AI ETI LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik ×6 filings | Oct. 16, 2025 | 0.00% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 21 insiders · 10 officers · 13 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Aoife Brennan | President and CEO | June 27, 2026 M | 87,731 | 0 | 1 | $-406,979 |
| Robert Azelby | President & CEO | Oct. 31, 2022 A | · | 0 | 0 | $0 |
| Susan Altschuller | Chief Financial Officer | Jan. 6, 2026 A | · | 0 | 0 | $0 |
| Erin Lavelle | COO & CFO | Oct. 31, 2022 A | · | 0 | 0 | $0 |
| Brett Kaplan | Chief Operating Officer | Aug. 26, 2024 A | · | 0 | 0 | $0 |
| Perrin Megan Wilson | Chief Business Officer | Jan. 6, 2026 A | · | 0 | 0 | $0 |
| Cindy Driscoll | Senior Vice President, Finance | Jan. 6, 2026 A | · | 0 | 0 | $0 |
| Emily Pimblett | SVP, Finance & CAO | June 18, 2025 M | 18,888 | 0 | 0 | $0 |
| Valerie Morisset | EVP, R&D AND CSO | July 22, 2024 S | 31,317 | 0 | 0 | $0 |
| James B Bucher | EVP and General Counsel | Oct. 31, 2022 A | · | 0 | 0 | $0 |
| Stephen Basil Thomas | Director | Sept. 15, 2026 S | 467,969 | 0 | 5 | $-2,245,963 |
| Breanna Maurine Celebi | Director | June 29, 2026 A | · | 0 | 0 | $0 |
| Andrew David Levin | Director | June 5, 2026 A | · | 0 | 0 | $0 |
| Judith Dunn | Director | June 5, 2026 A | · | 0 | 0 | $0 |
| Alexander Cumbo | Director | June 5, 2026 A | · | 0 | 0 | $0 |
| Kimberlee C Drapkin | Director | June 5, 2026 A | · | 0 | 0 | $0 |
| Douglas E Williams | Director | June 5, 2026 A | · | 0 | 0 | $0 |
| Simon Tate | Director | June 26, 2024 A | · | 0 | 0 | $0 |
| Adam Joseph Rosenberg | Director | June 26, 2024 A | · | 0 | 0 | $0 |
| Liam Ratcliffe | Director | June 26, 2024 A | · | 0 | 0 | $0 |
| Leone D Patterson | Director | May 19, 2022 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 18 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VAMO · Cambria ETF Trust | 0.84% | 76,753 NS | July 31, 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0.70% | 27,171 NS | July 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.12% | 119,861 SH | Sept. 11, 2026 | Daily |
| FFSM · FIDELITY COVINGTON TRUST | 0.11% | 133,441 NS | July 31, 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 17,165 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.02% | 914,481 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.02% | 145,416 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 16,764 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 202,877 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 16,698 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 76,929 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 14,520 SH | Sept. 8, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.00% | 8,176 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 13,817 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 292,463 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,366,686 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,917 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 195,031 SH | Sept. 11, 2026 | Daily |
CLYM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 21 analysts
BUY
Median target
$26.50
+142.2%
10 47.6%
Strong Buy
10 47.6%
Buy
1 4.8%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
14 analysts · 2026-10-04Mean target $27.57 +152.0%
← Below all targets
Current price $10.94
Low$18.00
Mean$27.57
High$40.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CLYM | $191M | -4.5 | · | · | -34.6% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | · |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| CTMX | $725M | · | -44.8% | -22.8% | -15.9% | · |
| SGMT | · | -3.7 | · | · | -42.3% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026